Related Experiment Video
Updated: Jan 11, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
HPCSMN: A Classification Method of Chemotherapy Sensitivity of Hypopharyngeal Cancer Based on Multimodal Network
Weiqi Fu1, Haiyan Li2, Xiongwen Quan3
1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Engineering Research Center of Trusted Behavior Intelligence, Ministry of Education, College of Artificial Intelligence, Nankai University, Tianjin, 300350, China.
None:
The treatment of hypopharyngeal cancer faces complex challenges, and accurate prediction of chemotherapy sensitivity is crucial for personalized treatment. In this study, a multimodal fusion network based on deep learning was used to classify the chemotherapy sensitivity of hypopharyngeal cancer, and the prediction accuracy was improved by integrating 3D CT images and radiomic features. The preprocessed and enhanced 3D CT images were analyzed by 3D ResNet branches to extract spatial features; the radiomic features screened by LASSO regression were processed by three layers of fully connected branches to analyze the tabular data. The extracted vectors were fused by fully connected layers, using complementary advantages to capture complex spatial dependencies and detailed radiomic features. Experiments on the manually segmented NKU-TMU-hphc dataset (containing 102 hypopharyngeal cancer CT images) showed that the multimodal fusion network had high accuracy and outperformed single-modality methods and other models in multiple evaluation indicators. Statistical analysis was performed on the extracted features and clinical characteristics. The model effectively integrates image and clinical data, provides a new method for chemotherapy sensitivity classification, and is expected to improve personalized medicine.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

